We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current LFCR market cap is 228.45M. The company's latest EPS is USD 0.3245 and P/E is 19.01.
| Quarter End | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 | Nov 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 30.15M | 35.7M | 37.89M | 24.71M | 32.56M |
| Operating Income | -1.47M | -896k | 2.15M | -11.58M | -1.96M |
| Net Income | 14.22M | 15.63M | -7.08M | -16.23M | -8.7M |
| Year End 26 May 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 590.37M | 544.16M | 185.79M | 105.38M | 128.26M |
| Operating Income | -38.54M | -13.5M | -41.29M | -21.8M | -8.84M |
| Net Income | -38.19M | -32.67M | -97.43M | -99.56M | 12.01M |
| Quarter End | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 | Nov 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 245.82M | 246.24M | 253.96M | 246.82M | 255.39M |
| Total Liabilities | 203.47M | 186.81M | 200.06M | 207.32M | 195.63M |
| Total Equity | 1.42M | 17.69M | 11.32M | -3.94M | 15.45M |
| Year End 26 May 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 541.31M | 502.92M | 295.16M | 253.55M | 253.96M |
| Total Liabilities | 310.27M | 300.14M | 187.22M | 218.46M | 200.06M |
| Total Equity | 231.04M | 202.78M | 107.95M | -4.23M | 11.32M |
| Quarter End | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 | Nov 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.32M | -8.86M | -217k | -643k | -6.75M |
| Investing | -9.03M | -15.28M | -17.92M | -3.39M | -5.86M |
| Financing | 486k | 8.12M | 7.51M | 1.09M | 13.61M |
| Year End 26 May 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -17.04M | 15.02M | -24.3M | -17.44M | -217k |
| Investing | -23.89M | -10.86M | 81.77M | -4.81M | -17.92M |
| Financing | 40.02M | -3.42M | -57.02M | 39.7M | 7.51M |
| Market Cap | 228.45M |
| Price to Earnings Ratio | 19.01 |
| Price to Sales Ratio | 1.78 |
| Price to Cash Ratio | 27 |
| Price to Book Ratio | 4.24 |
| Dividend Yield | - |
| Shares Outstanding | 37.03M |
| Average Volume (1 week) | 129.14k |
| Average Volume (1 Month) | 114.92k |
| 52 Week Change | -22.10% |
| 52 Week High | 8.0093 |
| 52 Week Low | 3.6793 |
| Spread (Intraday) | 0.72 (11.15%) |
| Company Name | Lifecore Biomedical Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.lifecore.com |
| Industry | plastics,resins,elastomers (2821) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
